A wireless brain implant for treatment-resistant depression has received FDA clearance for human trials in the United States.

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Over the past 12 months, XCS has changed by 76.28%, with its 52-week range spanning from 20.44 to 37.79. What Is the Daily Trading Range for XCS? The daily trading range for XCS has fluctuated between ...

The FDA has granted Motif Neurotech approval to begin human trials of its Motif XCS System, a brain implant aimed at treatment‑resistant depression. The RESONATE study will follow patients for a year ...

Holy odd-looking gadget, Batman! Certainly one of the oddest PC concepts ever, the Dell XCS attempts to simplify the inner workings of computers to make life easier for those who aren't ...